510 related articles for article (PubMed ID: 27189881)
1. Modulation of pain, nociception, and analgesia by the brain reward center.
Mitsi V; Zachariou V
Neuroscience; 2016 Dec; 338():81-92. PubMed ID: 27189881
[TBL] [Abstract][Full Text] [Related]
2. The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities.
Serafini RA; Pryce KD; Zachariou V
Biol Psychiatry; 2020 Jan; 87(1):64-73. PubMed ID: 31806085
[TBL] [Abstract][Full Text] [Related]
3. Pain relief induces dopamine release in the rat nucleus accumbens during the early but not late phase of neuropathic pain.
Kato T; Ide S; Minami M
Neurosci Lett; 2016 Aug; 629():73-78. PubMed ID: 27369326
[TBL] [Abstract][Full Text] [Related]
4. Positive emotions and brain reward circuits in chronic pain.
Navratilova E; Morimura K; Xie JY; Atcherley CW; Ossipov MH; Porreca F
J Comp Neurol; 2016 Jun; 524(8):1646-52. PubMed ID: 26788716
[TBL] [Abstract][Full Text] [Related]
5. Alcohol: mechanisms along the mesolimbic dopamine system.
Engel JA; Jerlhag E
Prog Brain Res; 2014; 211():201-33. PubMed ID: 24968782
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid modulation of drug reward and the implications of marijuana legalization.
Covey DP; Wenzel JM; Cheer JF
Brain Res; 2015 Dec; 1628(Pt A):233-43. PubMed ID: 25463025
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic modulation of pain signals in the medial prefrontal cortex: Challenges and perspectives.
Huang S; Borgland SL; Zamponi GW
Neurosci Lett; 2019 May; 702():71-76. PubMed ID: 30503912
[TBL] [Abstract][Full Text] [Related]
8. Role of the Prefrontal Cortex in Pain Processing.
Ong WY; Stohler CS; Herr DR
Mol Neurobiol; 2019 Feb; 56(2):1137-1166. PubMed ID: 29876878
[TBL] [Abstract][Full Text] [Related]
9. The mesolimbic dopamine reward circuit in depression.
Nestler EJ; Carlezon WA
Biol Psychiatry; 2006 Jun; 59(12):1151-9. PubMed ID: 16566899
[TBL] [Abstract][Full Text] [Related]
10. Reward Circuitry in Addiction.
Cooper S; Robison AJ; Mazei-Robison MS
Neurotherapeutics; 2017 Jul; 14(3):687-697. PubMed ID: 28324454
[TBL] [Abstract][Full Text] [Related]
11. Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat.
Pascual M; Boix J; Felipo V; Guerri C
J Neurochem; 2009 Feb; 108(4):920-31. PubMed ID: 19077056
[TBL] [Abstract][Full Text] [Related]
12. Functional magnetic resonance imaging in awake transgenic fragile X rats: evidence of dysregulation in reward processing in the mesolimbic/habenular neural circuit.
Kenkel WM; Yee JR; Moore K; Madularu D; Kulkarni P; Gamber K; Nedelman M; Ferris CF
Transl Psychiatry; 2016 Mar; 6(3):e763. PubMed ID: 27003189
[TBL] [Abstract][Full Text] [Related]
13. Role of dopamine D2-like receptors within the ventral tegmental area and nucleus accumbens in antinociception induced by lateral hypothalamus stimulation.
Moradi M; Yazdanian M; Haghparast A
Behav Brain Res; 2015 Oct; 292():508-14. PubMed ID: 26166189
[TBL] [Abstract][Full Text] [Related]
14. Brain Reward Circuit and Pain.
Watanabe M; Narita M
Adv Exp Med Biol; 2018; 1099():201-210. PubMed ID: 30306526
[TBL] [Abstract][Full Text] [Related]
15. Microglia disrupt mesolimbic reward circuitry in chronic pain.
Taylor AM; Castonguay A; Taylor AJ; Murphy NP; Ghogha A; Cook C; Xue L; Olmstead MC; De Koninck Y; Evans CJ; Cahill CM
J Neurosci; 2015 Jun; 35(22):8442-50. PubMed ID: 26041913
[TBL] [Abstract][Full Text] [Related]
16. Inputs from the basolateral amygdala to the nucleus accumbens shell control opiate reward magnitude via differential dopamine D1 or D2 receptor transmission.
Lintas A; Chi N; Lauzon NM; Bishop SF; Sun N; Tan H; Laviolette SR
Eur J Neurosci; 2012 Jan; 35(2):279-90. PubMed ID: 22236063
[TBL] [Abstract][Full Text] [Related]
17. NMDA and dopamine D1 receptors within NAc-shell regulate IEG proteins expression in reward circuit during cocaine memory reconsolidation.
Li Y; Ge S; Li N; Chen L; Zhang S; Wang J; Wu H; Wang X; Wang X
Neuroscience; 2016 Feb; 315():45-69. PubMed ID: 26674058
[TBL] [Abstract][Full Text] [Related]
18. Quantifying cerebral contributions to pain beyond nociception.
Woo CW; Schmidt L; Krishnan A; Jepma M; Roy M; Lindquist MA; Atlas LY; Wager TD
Nat Commun; 2017 Feb; 8():14211. PubMed ID: 28195170
[TBL] [Abstract][Full Text] [Related]
19. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.
Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK
Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260
[TBL] [Abstract][Full Text] [Related]
20. Targeting the affective and cognitive aspects of chronic neuropathic pain using basal forebrain neuromodulation: rationale, review and proposal.
Oluigbo CO; Salma A; Rezai AR
J Clin Neurosci; 2012 Sep; 19(9):1216-21. PubMed ID: 22771143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
